60
Participants
Start Date
June 17, 2024
Primary Completion Date
May 31, 2025
Study Completion Date
May 31, 2027
neoadjuvant anti-PD-1
PD-1 inhibitor (toripalimab) 240mg, day 1，every 3 weeks, 2 cycles. Postoperative adjuvant treatment: according to the recommendations of the guidelines and the investigators
neoadjuvant anti-PD-1 with LDRT
"Radiotherapy: low-dose radiotherapy (LDRT), gross target volume (GTV), DT: 1Gy (day1), 1Gy (day2), every 3 weeks, 2 cycles.~PD-1 inhibitor (toripalimab) 240mg, day 3，every 3 weeks, 2 cycles. Postoperative adjuvant treatment: according to the recommendations of the guidelines and the investigators"
RECRUITING
Shanghai Chest Hospital, Shanghai
Shanghai Chest Hospital
OTHER